95090 ⎘
Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom; Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings [b,e]-condensed
TAAR1 AND SEROTONIN MODULATORS, AND PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
#2CENTRALLY ACTIVE P38ALPHA INHIBITING COMPOUNDS
#3SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME
#4SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME
#5OXADIAZOLINE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISMS
#6Compositions and methods for the treatment of mucositis
#7Process for the synthesis of olopatadine
#8Process for the preparation of olopatadine and sylil intermediates thereof
#9Tricyclic compound and use thereof
#10Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
#11PROCESS FOR THE PREPARATION OF PHARMACEUTICAL INTERMEDIATES
#12Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
#13Oligomer-tricyclic conjugates
#14Process for the preparation of olopatadine
#15Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#16Pharmaceutical and food compositions for preventing or treating diabetes or obesity
#17Dibenzocycloheptatone derivatives and pharmaceutical agents containing said compounds
#18FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#19Process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof
#20Process for obtaining olopatadine and intermediates
#21INHIBITORS OF HISTONE DEACETYLASE
#22Process for the preparation of olopatadine
#23Oligomer-tricyclic conjugates
#24Process for preparing N-alkylated hydroxypyrimidinone compounds
#25OXEPINE MODULATORS OF H1 RECEPTORS AND/OR INHIBITORS OF MAST CELL DEGRANULATION
#26CRYSTALLINE POLYMORPHIC FORMS OF OLOPATADINE HYDROCHLORIDE AND PROCESSES FOR THEIR PREPARATION
#27Organic electroluminescent devices
#28TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#29Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
#30DEUTERIUM-ENRICHED OLOPATADINE
#3111—[ (Z) -3- (dimethylamino) propylidene]—6, 11-dihydro-dibenz [B,E] oxepin-2-YI ]—acetic acid
#32Preventive and/or Therapeutic Agent for Sleeping Disorder
#33Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#34Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
#35Preventive and/or Therapeutic Agent for Chronic Sinusitis
#36Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
#37Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods
#38Potassium salt of an HIV integrase inhibitor
#39Tricyclic steroid hormone nuclear receptor modulators
#40Amino substituted hydroxyphenyl benzophenone derivatives
#41Dihydro-dibenzo[b,e]oxepine based selective estrogren receptor modulators, compositions and methods
#42Treatment of CNS disorders using CNS target modulators
#43Chemokine receptor antagonists and methods of use thereof
#44Treatment of cns disorders using cns target modulators